Pharmaceutical giant reveals it is partnering with Honeywell to develop a new inhaler propellant that has 99.9 per cent less Global Warming Potential than current models
It may be one of the most surprising sources of greenhouse gas emissions, but now pharmaceutical giant AstraZeneca thinks it has worked out to tackle the climate damage caused by respiratory inhalers....
To continue reading this article...
Join BusinessGreen
In just a few clicks you can start your free BusinessGreen Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis, and opinion from Europe’s leading source of information on the Green economy and business
- Receive important and breaking news stories via our daily news alert
- Our weekly newsletter with the best of the week’s green business news and analysis
